Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comments on risk for schizophrenia.

Mark Weiser1, Michael Davidson, Shlomo Noy

  • 1Department of Psychiatry, Sheba Medical Center, Tel-Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel. mweiser@netvision.net.il

Schizophrenia Research
|June 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe Hypertriglyceridemia Managed in a Pregnant Patient Using Nonstatin Therapies.

JACC. Case reports·2026
Same author

Negative symptoms in schizophrenia: Methodological challenges and emerging solutions for outcome measurement.

Neuroscience applied·2026
Same author

Xanomeline/trospium and suicide-related events in schizophrenia: An early pharmacovigilance analysis.

Schizophrenia research·2026
Same author

Moderate to severe negative symptoms predict low risk of symptoms worsening in schizophrenia patients in CATIE.

Schizophrenia research·2026
Same author

Modeling Negative Symptom Domain Neurobiology: Protocol for an Observational, Transdiagnostic, Translational Study.

JMIR research protocols·2026
Same author

Quality of life in early-phase schizophrenia patients starting treatment with long-acting injectable vs. oral antipsychotic drugs: Data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST).

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals.

Schizophrenia research·2026
Same journal

FL-SDGIN: A federated graph learning approach for schizophrenia diagnosis integrating static and dynamic brain functional networks.

Schizophrenia research·2026
Same journal

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same journal

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same journal

Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

Schizophrenia research·2026
Same journal

One social interaction after another: Dynamic modeling of social experience in schizophrenia.

Schizophrenia research·2026
See all related articles

Understanding schizophrenia risk factors is improving. While genetics and environment play a role, their low predictive power for schizophrenia may increase with broader psychopathology risk assessment.

Area of Science:

  • Psychiatry
  • Genetics
  • Environmental Health

Background:

  • Schizophrenia risk is influenced by genetic and environmental factors.
  • Immigration, urban living, and substance abuse are associated with increased schizophrenia risk.
  • Monzygotic twins have a 50% risk, but current genetic markers offer minimal predictive value.

Purpose of the Study:

  • To explore the clinical utility of known schizophrenia risk factors.
  • To investigate if non-specific risk factors for general psychopathology can improve schizophrenia prediction.
  • To leverage higher base rates of psychopathology for clinical relevance of risk factors.

Main Methods:

  • Review of recent developments in schizophrenia risk factor research.
  • Analysis of genetic and environmental factors associated with schizophrenia.

Related Experiment Videos

  • Evaluation of the impact of risk factors on general psychopathology.

    • Main Results:

    • Genetic and environmental factors increase schizophrenia risk by only 2-3 fold.
    • These risk factors are often not specific to schizophrenia but increase general psychopathology risk.
    • The higher prevalence of general psychopathology (up to 50%) makes 2-3 fold risk increases clinically relevant.

    Conclusions:

    • Current genetic and environmental risk factors for schizophrenia have limited predictive power due to low prevalence.
    • Considering risk factors for general psychopathology may enhance clinical utility for schizophrenia prediction.
    • The broader applicability of risk factors to psychopathology could make them more useful in clinical settings.